OR WAIT null SECS
April 02, 2024
The European pharma industry needs to be prepared for the new clinical data requirements.
March 30, 2024
The company is voluntarily recalling the product for potential super potent bottles due to overfilling.
March 22, 2024
The company is recalling one lot of the product because of the potential presence of silicone particulates.
March 21, 2024
More synthetic opioids have been placed under the strictest controls in the United Kingdom.
March 15, 2024
The draft guidance document provides support to sponsors with drugs in clinical development that treat the states of sporadic Alzheimer’s disease.
March 11, 2024
The Alliance will receive the NSF Regional Innovation Engines Development Award and $1 million in funding.
March 08, 2024
EMA plans to add 10 partners to its real-world data initiative, DARWIN EU, in 2024.
March 07, 2024
FDA has published final guidance documents regarding validation and development of analytical procedures.
New plans laid out by AstraZeneca will see £650 million ($828 million) be invested into the UK.
March 04, 2024
Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.